• 1
    Blanchon F, Grivaux M, Asselain B et al. 4-Year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol. 2006; 10: 829836.
  • 2
    Jones LW, Cohen RR, Mabe SK et al. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J. Neurooncol. 2009; 94: 7985.
  • 3
    Blair SN, Kannel WB, Kohl HW et al. Surrogate measures of physical activity and physical fitness. Evidence for sedentary traits of resting tachycardia, obesity, and low vital capacity. Am. J. Epidemiol. 1989; 129: 11451156.
  • 4
    Blair SN, Kohl HW, Paffenbarger RS et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989; 262: 23952401.
  • 5
    Jones LW, Eves ND, Peterson BL et al. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical non-small cell lung cancer patients: a pilot study. Cancer 2008; 113: 34303439.
  • 6
    Jones LW, Eves ND, Mackey JR et al. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 2007; 55: 225232.
  • 7
    Jones LW, Watson D, Herndon JE et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer 2010; 116: 48254832.
  • 8
    Loewen GM, Watson D, Kohman L et al. Pre-operative exercise VO2 measurement for lung resection candidates: results of cancer and leukemia group B protocol 9238. J. Thorac. Oncol. 2007; 2: 619625.
  • 9
    Jones LW, Eves ND, Haykowsky M et al. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008; 9: 757765.
  • 10
    American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 2003; 167: 211277.
  • 11
    Colice GL, Shafazand S, Griffin JP et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132: 161S177.
  • 12
    Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 1982; 5: 649655.
  • 13
    Balady GJ, Larson MG, Vasan RS et al. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score. Circulation 2004; 110: 19201925.